A clinical trial of mifepristone alone versus mifepristone -misoprostol combination regimen for induction of labor in late intrauterine fetal death.

Randomized control study of mifepristone alone versus mifepristone -misoprostol combination regimen for induction of labor in late intrauterine fetal death. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105237

Enrollment

Registered

2026-03-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O364- Maternal care for intrauterine death

Interventions

Intervention1: Induction of labor in late intrauterine fetal death.: Induction of labor with Tablet Mifepristone 200 milligrams per orally thrice daily for two days in late intrauterine fetal death wh

Eligibility

Inclusion criteria

Inclusion criteria: Singleton pregnancy with late intrauterine fetal death and non-scarred uterus.

Exclusion criteria

Exclusion criteria: 1.Deranged liver function tests/ kidney function tests/ coagulation profile. 2.Known allergy or contraindication for Mifepristone or Misoprostol. 3.Known case of inherited porphyria.

Design outcomes

Primary

Measure	Time frame
Proportion of women who deliver vaginally with Mifepristone alone vs Mifepristone- Misoprostol combination regimen within 5 days of initiation of regimen. Timepoint: Proportion of women who deliver vaginally with Mifepristone alone vs Mifepristone- Misoprostol combination regimen within 5 days of initiation of regimen.	—

Secondary

Measure	Time frame
1.Mean induction to delivery time in both regimens 2.Proportion of women requiring additional intervention (medical/ surgical). Timepoint: Women who deliver vaginally within 5 days of initiation of regimen.	—

Countries

India

Contacts

Public ContactDr Komal Yadav

Maulana Azad Medical College

komalmamc2000@gmail.com8447605286

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026